|
Berthelot, Claire C; Kamita, Shizuo George; Sacchi, Romina et al. (2015) Changes in PTGS1 and ALOX12 Gene Expression in Peripheral Blood Mononuclear Cells Are Associated with Changes in Arachidonic Acid, Oxylipins, and Oxylipin/Fatty Acid Ratios in Response to Omega-3 Fatty Acid Supplementation. PLoS One 10:e0144996
|
|
Nording, Malin L; Yang, Jun; Georgi, Katrin et al. (2013) Individual variation in lipidomic profiles of healthy subjects in response to omega-3 Fatty acids. PLoS One 8:e76575
|
|
Zivkovic, Angela M; Yang, Jun; Georgi, Katrin et al. (2012) Serum oxylipin profiles in IgA nephropathy patients reflect kidney functional alterations. Metabolomics 8:1102-1113
|
|
Hogg, Ronald J; Lee, Jeannette; Nardelli, Nancy et al. (2006) Clinical trial to evaluate omega-3 fatty acids and alternate day prednisone in patients with IgA nephropathy: report from the Southwest Pediatric Nephrology Study Group. Clin J Am Soc Nephrol 1:467-74
|
|
Hogg, Ronald J; Fitzgibbons, Lisa; Atkins, Carolyn et al. (2006) Efficacy of omega-3 fatty acids in children and adults with IgA nephropathy is dosage- and size-dependent. Clin J Am Soc Nephrol 1:1167-72
|
|
Novak, J; Julian, B A; Tomana, M et al. (2001) Progress in molecular and genetic studies of IgA nephropathy. J Clin Immunol 21:310-27
|
|
Julian, B A; Tomana, M; Novak, J et al. (1999) Progress in the pathogenesis of IgA nephropathy. Adv Nephrol Necker Hosp 29:53-72
|
|
Hogg, R J (1995) A randomized, placebo-controlled, multicenter trial evaluating alternate-day prednisone and fish oil supplements in young patients with immunoglobulin A nephropathy. Scientific Planning Committee of the IgA Nephropathy Study. Am J Kidney Dis 26:792-6
|
